Literature DB >> 1506637

Assessment of the renin-angiotensin system in cirrhotic patients. Comparison between plasma renin activity and direct measurement of immunoreactive renin.

M Asbert1, W Jiménez, J Gaya, P Ginés, V Arroyo, F Rivera, J Rodés.   

Abstract

The renin-angiotensin system plays an important physiological role and has prognostic significance in cirrhotics with ascites. The degree of stimulation of this system is usually estimated by measuring plasma renin activity after incubation periods of 2-3 h. Recent investigations showed that the direct measurement of immunoreactive renin also estimates the degree of activity of the system. In this study, immunoreactive renin and plasma renin activity (measured at incubation periods of 10, 20, 50 and 180 min) were determined in ten healthy subjects, five hyperreninemic non-hepatic patients and 47 cirrhotics with ascites. Cirrhotic patients showed significantly higher plasma renin activity (5.1 +/- 0.9 ng/ml per h, p less than 0.05) and immunoreactive renin (145.4 +/- 24.4 pg/ml, p less than 0.01) than healthy subjects (1.2 +/- 0.15 ng/ml per h and 25.1 +/- 1.1 pg/ml, respectively). The angiotensin I generation rate was constant during the 3-h incubation in 22 cirrhotics and a close relationship (r = 0.956, p less than 0.001) between plasma renin activity (3.5 +/- 1.6 ng/ml per h) and immunoreactive renin (71 +/- 25 pg/ml) was observed in these patients. In the remaining 25 cirrhotics the generation rate of angiotensin I declined with time and the calculated plasma renin activity at 180 min was lower than the activity calculated at 10 min by 50.7%.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1506637     DOI: 10.1016/0168-8278(92)90033-l

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  13 in total

1.  Does angiotensin II type 1 receptor blockade offer a clinical advantage to cirrhotics with ascites?

Authors:  Hiroshi Fukui
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

Review 2.  The enigma of continual plasma volume expansion in pregnancy: critical role of the renin-angiotensin-aldosterone system.

Authors:  Crystal A West; Jennifer M Sasser; Chris Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2016-10-05

3.  ACEI attenuates the progression of CCl4-induced rat hepatic fibrogenesis by inhibiting TGF-beta1, PDGF-BB, NF-kappaB and MMP-2,9.

Authors:  Xu Li; Ying Meng; Xi-Shan Yang; Ling-Fei Mi; Shao-Xi Cai
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

4.  Value of direct measurement of active renin concentrations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  C Krüger; K Höper; R Weissörtel; J Hensen; H G Dörr
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

5.  Anemia worsens hyperdynamic circulation of patients with cirrhosis and portal hypertension.

Authors:  I Cirera; J I Elizalde; J M Piqué; F Feu; M Casadevall; E Goldin; J Terés; J Bosch; J Rodés
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

6.  Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study.

Authors:  R Moreau; T Asselah; B Condat; C de Kerguenec; F Pessione; B Bernard; T Poynard; M Binn; J D Grangé; D Valla; D Lebrec
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

7.  Renal distal tubular handling of sodium in central fluid volume homoeostasis in preascitic cirrhosis.

Authors:  G Sansoè; A Ferrari; E Baraldi; C N Castellana; M C De Santis; F Manenti
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

8.  NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis.

Authors:  Ramon Bataller; Robert F Schwabe; Youkyung H Choi; Liu Yang; Yong Han Paik; Jeffrey Lindquist; Ting Qian; Robert Schoonhoven; Curt H Hagedorn; John J Lemasters; David A Brenner
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

9.  Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C.

Authors:  Jordi Colmenero; Ramón Bataller; Pau Sancho-Bru; Marlene Domínguez; Montserrat Moreno; Xavier Forns; Miquel Bruguera; Vicente Arroyo; David A Brenner; Pere Ginès
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-07-23       Impact factor: 4.052

Review 10.  NOX in liver fibrosis.

Authors:  Samuele De Minicis; David A Brenner
Journal:  Arch Biochem Biophys       Date:  2007-05-02       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.